President/CEO Solvotrin Therapeutics Ltd
Pat is an entrepreneur with a proven international business track record with over fifteen years’ experience, including the Pharma Chem industry. Pat was previously CEO of AVR-Safeway Limited, a company which he co-founded and in which he created significant shareholder value. The company was sold to international utility company Veolia in 2008.
Pat has successfully managed joint ventures and collaborations with leading international companies. Pat was a finalist in the 2008 Ernst and Young Entrepreneur of the Year Award. He holds academic qualifications in Mechtronic Engineering, Business Management, Corporate Finance and Leadership from IMD Switzerland.
Pat’s role includes leading the company to attain its vision and mission, maintain key relationships effectively, recruit and manage performance of staff, prepare initial strategy drafts and implement strategy approved by the Board, propose budgets to the board for approval, put in place and operate systems and management structure to secure effective governance. Pat is also responsible for providing the Chair and Board with reports on key performance, conformance and other issues, anticipating and informing the board of risks to strategy, managing all statutory and regulatory compliance requirements as well as keeping the Chair fully briefed on all relevant matters.